Imago BioSciences stock soars after Merck bids more than 100% premium to buy the biotech
Shares of Imago BioSciences Inc. IMGO, +104.54% soared 104.9% into record territory in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms (MPNs) and other…
Read more Imago BioSciences stock soars after Merck bids more than 100% premium to buy the biotech